State-of-the-Art Review: Vaccination in Pediatric Dermatology Patients Receiving Immunosuppressive or Immunomodulatory Therapy: A Review.

Increased use of off-label and FDA-approved medications, especially at younger ages, decreases disease burden and mortality.

The earlier usage of these immunosuppressants often parallels the pediatric vaccine schedule.

Successful treatment of dermatologic conditions while enabling children to mount an adequate immunologic response to preventable diseases necessitates partnering between dermatologists and primary care physicians.

Understanding the guidelines will enable dermatologists to better educate patients and engage in shared decision-making.